Circulating Interferon in Rabbits after Administration of Human Interferon by Different Routes

References

1. Baron S., Buckler C. E., Mccloskey R. V., Kirschstein R. L. 1966; Role of interferon during viremia. I. Production of circulating interferon. Journal of Immunology 96:12–16
   [Google Scholar]
2. Billiau A. 1969; Systemic induction of interferon. Thesis University of Leuven; Belgium:
   [Google Scholar]
3. Bocci V., Russi-Sorce M., Cirri G., Rita G., Cantagalli P. 1968; Virus-induced interferon in the rabbit: distribution, fate, and characterization of urinary interferon. In The Interferons Pp 37–54 Edited by Rita G. London: Academic Press;
   [Google Scholar]
4. Cantell K. 1970; Preparation of human leukocyte interferon. Symposia Series in Immunological Standardi zation 14:6–8 New York: Basel and Karger;
   [Google Scholar]
5. Cantell K., Ktrander H., Hadhazy GY., Nevanlinna H. R. 1968; How much interferon can be prepared in human leukocyte suspensions. In The Interferons Pp 223–232 Edited by Rita G. London: Academic Press;
   [Google Scholar]
6. Desmyter J., Rawls W. E., Melnick J. L. 1968; A human interferon that crosses the species line. Proceedings of the National Academy of Sciences of the United States of America 59:69–76
   [Google Scholar]
7. Finter N. B. 1966; Interferon as an antiviral agent in vivo: quantitative and temporal aspects of the protection of mice against Semliki Forest virus. British Journal of Experimental Pathology 47:361–371
   [Google Scholar]
8. Gresser I., Fontaine D., Coppey J., Falcoff R., Falcoff E. 1967; Interferon and murine leukemia. II. Factors related to the inhibitory effect of interferon preparations on development of Friend leukemia in mice. Proceedings of the Society for Experimental Biology and Medicine 124:91–94
   [Google Scholar]
9. Ho M., Postic B. 1967; Prospects for applying interferon to man. In First International Conference on Vaccines against Viral and Rickettsial Diseases of Man Pp 632–649 Washington, D.C.: Pan American Health Organization;
   [Google Scholar]
10. International Symposium on Standardization Of Interferon And Interferon Inducers, London 1969 Symposia Series in Immunological Standardization 14 326–327 Basel and New York: Karger;
    [Google Scholar]
11. Levy-Koenig R. E., Golgher R. R., Paucker K. 1970a; Immunology of interferons. II. Heterospecific activities of human interferons and their neutralization by antibody. Journal of Immunology 104:791–97
    [Google Scholar]
12. Levy-Koenig R. E., Mundy M. J., Paucker K. 1970b; Immunology of interferons. I. Immune response to protective and nonprotective interferons. Journal of Immunology 104:785–790
    [Google Scholar]
13. Nuwer M. R., De Clercq E., Merigan T. C. 1971; Interferon clearance rate decreased after repeated injections. Journal of General Virology 12:191–194
    [Google Scholar]
14. Pinto C. A., Haff R. F., Valenta J. R., Pagano J. F., Dicuollo C. J., Ferlauto R. J. 1970; Human interferon II. Biological activity. Symposia Series in Immunological Standardization 14:105–112 Basel and New York: Karger;
    [Google Scholar]
15. Schafer T. W., Lieberman M., Cohen M., Came P. E. 1972; Interferon administered orally; protection of neonatal mice from lethal virus challenge. Science 176:1326–1327
    [Google Scholar]
16. Strander H., Cantell K. 1966; Production of interferon by human leukocytes in vitro. Annales Medicinae Experimentalis et Biologiae Fenniae 44:265–273
    [Google Scholar]
17. Strander H., Cantell K. 1967; Further studies on the production of interferon by human leukocytes in vitro. Annales Medicinae Experimentalis et Biologiae Fenniae 45:20–29
    [Google Scholar]
18. Subrahmanyan T. P., Mims C. A. 1966; Fate of intravenously administered interferon and the distribution of interferon during virus infections in mice. British Journal of Experimental Pathology 47:168–176
    [Google Scholar]